Oligomerix Lands NIA Grant for Alzheimer's Biomarker Research | GenomeWeb

NEW YORK (GenomeWeb News) — Oligomerix said today that it has received a $323,000 grant from the National Institutes of Health's National Institute on Aging for research that could lead to diagnostic assays for Alzheimer's disease.

The New York, NY-based company plans to use the Small Business Innovation Research funding to develop a test that could monitor proteins in cerebrospinal fluid and plasma from AD patients. This research will be conducted by researchers at Columbia University Medical Center.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.